PETX

Aratana Therapeutics, Inc.
PETX

Overview Fund Activity
Delisted

PETX was delisted on the 17th of July, 2019.

Back to rankings

32 hedge funds and large institutions have $157M invested in Aratana Therapeutics, Inc. in 2013 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.

Holders
32
Holders Change
+19
Holders Change %
+146.15%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
21
Increased
3
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MAM
1
MPM Asset Management
Massachusetts
$71.1M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$14M
3
BFA
3
BlackRock Fund Advisors
California
$3.02M
4
BIT
4
BlackRock Institutional Trust
California
$1.22M
5
Goldman Sachs
5
Goldman Sachs
New York
$1.11M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$7.38M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$7.4M
3
HHC
3
Hutchin Hill Capital
New York
$1.88M
4
KIA
4
Kopp Investment Advisors
Minnesota
$575K
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$3.62M
Name Holding Trade Value Shares
Change 		Shares
Change %
BG
26
BlackRock Group
United Kingdom
$78K +$78K +4,783 New
SO
27
STRS Ohio
Ohio
$49K +$49K +3,000 New
BA
28
BlackRock Advisors
Delaware
$48K +$48K +2,944 New
NFA
29
Nationwide Fund Advisors
Ohio
$31K +$31K +1,908 New
U
30
UBS
Switzerland
$28K +$28K +1,704 New
Barclays
31
Barclays
United Kingdom
$9K +$9K +561 New
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$5K +$5K +300 New
RSCM
33
Rail-Splitter Capital Management
Illinois
– -$189K -25,000 Closed
1
2